Durham’s BioAgilytix Continues Growth Spurt; Plans to Add More Jobs

BioAgilytix doubled its customer base from 2013 to 2014 and already doubled again by August of this year. The company has 60 percent organic year-over-year growth and Datin expects to acquire a company in Europe by the end of the year. Last year, it worked with 12 of the 25 largest pharmaceutical and biotechnology companies, a figure that has increased to 19 this year.

Click for full article
Share This

Other Podcasts

Welcome to episode one of the Molecular Moments podcast! On this first episode, Dr. Chad Briscoe is joined by his guest, Ph.D scientist, Dr. Jim McNally, and they get down to business as the two explore the various nuances in the outstanding work of McNally, how his career in bioanalysis became personal in an unexpected…
In today’s episode, Dr. Chad Briscoe sits down with guest scientist and biomarker expert, Dr. Marianne Fjording (Scientific Officer, BioAgilytix). Marianne and Chad discuss her expertise in biomarkers and EU bioanalysis- including how Denmark became a scientific hub and what fit-for-purpose really means. They also dive into Marianne’s jump from pharma to CRO, a family…